This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a morpholine ring and cyclohexylamine moiety, makes it a valuable intermediate in the creation of compounds targeting various biological pathways. It is often employed in the development of central nervous system (CNS) drugs, where its ability to modulate neurotransmitter systems is of interest. Additionally, it serves as a building block in the design of molecules with potential analgesic or anti-inflammatory properties. Its hydrochloride form enhances solubility, making it suitable for use in experimental formulations and preclinical studies.